AUVEN THERAPEUTICS HOLDINGS LP 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-25 4:10 pm Sale | 2024-04-23 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.700% | -4,074,829 (-64.37%) | Filing |
| 2023-04-28 4:08 pm Unchanged | 2023-04-27 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% | 0 (Unchanged) | Filing |
| 2023-02-06 2:56 pm Sale | 2023-02-02 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% | -12,000,000 (-65.46%) | Filing |
| 2022-12-22 7:30 pm Unchanged | 2022-12-22 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% | 0 (Unchanged) | Filing |
| 2022-12-09 4:06 pm Sale | 2022-12-08 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% | -3,088,182 (-14.42%) | Filing |
| 2022-12-08 09:07 am Sale | 2022-12-08 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 21,418,730 27.800% | -775,000 (-3.49%) | Filing |
| 2020-10-13 5:26 pm Sale | 2020-10-09 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 22,193,730 28.900% | -1,400,000 (-5.93%) | Filing |
| 2020-05-29 11:54 am Purchase | 2020-05-19 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 23,593,730 33.400% | 23,593,730 (New Position) | Filing |